Industry news

Researchers at the St. Petersburg Peter the Great Polytechnic University (SPbPU) have pooled efforts with partners from other scientific and commercial entities to grow a prosthetic titanium hip joint, using a 3D printer, the university website announced.

Researchers from the St. Petersburg Peter the Great Polytechnic University and the Tomsk Polytechnic University are undertaking a joint project aimed at developing a brand new data visualization and storage technology for cardiac case records in clinics and hospitals, the St. Pete university announced.

International workshop “Molecular mechanisms of aging and aging-related diseases” will be held on 9th – 12th October, 2015, at the MIPT (Dolgoprudny, Russia) with the support of Project 5-100.

Gilead Sciences Inc., maker of the hepatitis C drugs Sovaldi and Harvoni, posted second-quarter profit that topped analysts’ estimates as revenue surged. Gilead raised its sales forecast for the year.

U.S. buyout firm Gores Group is weighing a sale of immunotherapy company Therakos amid a boom in health care deals, according to people with knowledge of the matter. Gores is working with Credit Suisse Group AG on the sale, which may value Therakos at about $1 billion, the people said, asking not to be identified because the process is private. Therakos may attract interest from other buyout firms and health care companies, the people said.

In his quest to create the first original, billion-dollar drug from a Chinese laboratory, Chen Li is zeroing in on one of the world’s fastest-growing patient groups: diabetes sufferers in China.

Clinical laboratory tests play a crucial role in making sure patients get appropriate care, yet many small labs and clinics in low resource settings cannot afford the instruments needed to provide these tests. Research on a novel fingerprick test that can perform all common clinical diagnostics could help to expand access to basic medical testing in the developing world, and will be featured at the 2015 AACC Annual Meeting & Clinical Lab Expo.

A ‘pill on a string’ developed by researchers at the University of Cambridge could help doctors detect oesophageal cancer – cancer of the gullet – at an early stage, helping them overcome the problem of wide variation between biopsies, suggests research published today in the journal Nature Genetics.